Tarsus Pharmaceuticals, Inc. Common Stock TARS

$70.76 +1.04% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 FORM 4 2026-09-17 View →
4 FORM 4 2026-09-17 View →
4 FORM 4 2026-09-17 View →
8-K 8-K 2026-09-10 View →
4 FORM 4 2026-09-09 View →
4 FORM 4 2026-09-09 View →
4 FORM 4 2026-09-09 View →
4 FORM 4 2026-09-03 View →
4 FORM 4 2026-09-03 View →
10-Q 10-Q 2026-08-06 View →
8-K 8-K 2026-08-06 View →
8-K 8-K 2026-08-06 View →
8-K 8-K 2026-08-06 View →
8-K 8-K 2026-07-13 View →
8-K 8-K 2026-07-08 View →
4 FORM 4 2026-06-29 View →
4 FORM 4 2026-06-29 View →
4 FORM 4 2026-06-29 View →
4 FORM 4 2026-06-29 View →
4 FORM 4 2026-06-29 View →
4 FORM 4 2026-06-29 View →
4 FORM 4 2026-06-29 View →
8-K 8-K 2026-06-29 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-17 View →
4 FORM 4 2026-06-17 View →
4 FORM 4 2026-06-17 View →
4 FORM 4 2026-06-16 View →
4 FORM 4 2026-06-16 View →
4 FORM 4 2026-06-16 View →
4 FORM 4 2026-06-16 View →
4 FORM 4 2026-06-16 View →
4 FORM 4 2026-06-16 View →
10-Q 10-Q 2026-05-06 View →
8-K 8-K 2026-05-06 View →
4 FORM 4 2026-04-28 View →
DEF 14A DEF 14A 2026-04-28 View →
4 FORM 4 2026-03-24 View →
4 FORM 4 2026-03-19 View →
4 FORM 4 2026-03-19 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$70.76
Market Cap
$3.28 billion
52-Week Range
$53.85 – $91.53
Average Volume
929K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.